Table 1.
Summary of in Vitro and in Silico Modeled Receptor Binding and in Vivo Tail-Flick Analgesiaa
K
i
|
||||||||
---|---|---|---|---|---|---|---|---|
compd | R1 | R2 | MOR-CHO (nM) |
MOR in silico (nM) |
DOR-CHO (nM) |
DOR in silico (nM) |
KOR-CHO (nM) |
in vivo ED50 (mg/kg)c |
4 | phenylethyl | cyclopropyl | 10.3 ± 5.1 | 13.79 | >100 | 54.73 | 87.6 ± 29 | 0.78 ± 0.26 |
5 | phenylethyl | cyclopentyl | 29.4 ± 15 | 4.29 | 90.7 ± 23 | 50.58 | >100 | 9.92 ± 0.08 |
6 | phenylethyl | cyclohexyl | 0.84 ± 0.34 | 0.66 | 2.65 ± 0.32 | 44.60 | 0.44 ± 0.05 | 3.10 ± 0.19 |
7 | phenylethyl | cycloheptyl | 2.66 ± 1.3 | 3.80 | 8.90 ± 7.7 | 7.90 | >100 | 10.0 ± 0.00 |
8 | phenylethyl | butyl | 21.1 ± 11 | 13.38 | 87.9 ± 4.8 | 244.5 | >100 | >10 |
9 | phenylethyl | t-butyl | 2.73 ± 2.2 | 3.65 | 71.2 ± 8.7 | 251.0 | >100 | 1.09 ± 0.05 |
10 | phenylethyl | isoamyl | 27.0 ± 20 | 24.15 | 27.0 ± 3.6 | 120.4 | >100 | >10 |
11 | phenylethyl | adamantyl | 25.0 ± 9.8 | 0.88 | 8.83 ± 0.63 | 7.65 | >100 | >10 |
12 | CPMb | cyclohexyl | >100 | >100 | >100 | >10 | ||
13 | CPMb | t-butyl | >100 | >100 | >100 | >10 | ||
DAMGO | 3.34 ± 0.43d | |||||||
morphine | 4.6 ± 1.81d | 5d | ||||||
U50,488H | 0.73 ± 0.32d | |||||||
DPDPE | 1.39 ± 0.67d |
Competition studies were performed with the indicated compounds against 125I-BNtxA (0.1 nM) in membranes from CHO cells stably expressing the indicated cloned mouse opioid receptors. Ki values were calculated from the IC50 values18 and represent the means ± SEM of at least three independent replications. In silico Inhibitory constants were calculated from the binding free energies obtained from docking (vide infra) according to the following equation: ΔH = RT ln Ki. 125IBNtxA KD values for MOR, KOR, and DOR sites were 0.11, 0.03, and 0.24, respectively.
CPM = cyclopropylmethyl.
Analgesia was determined using the radiant heat tail-flick technique on CD-1 mice as described in the Methods section.
Values from literature ref 25.